数千万元！柳叶刀机器人完成A+轮融资

Core Insights - The article highlights the successful A+ round financing of Shenzhen Liuye Knife Robot Co., Ltd., which raised several tens of millions of yuan to enhance its position in the domestic surgical robot market [1][4] - The company has achieved comprehensive localization of surgical robots through independent research and development, making its products widely used in various hospitals, including grassroots and private specialty hospitals [4][11] - Liuye Knife Robot is one of the first Chinese surgical robot manufacturers to obtain FDA registration, actively expanding its overseas market presence with over 20 overseas order contracts [4][11] Company Overview - Liuye Knife Robot was established in 2018 and focuses on multiple surgical fields, including joint replacement, spinal surgery, oral implantation, neurosurgery, and vascular intervention [11] - The company has built a comprehensive product line of surgical robots, supported by a strong R&D team with backgrounds in engineering and clinical medicine [11] Product Development - The company has developed the Robpath AI hip replacement surgical robot system, which features advanced capabilities such as automatic identification and segmentation of oral tissues, intelligent surgical planning, and real-time adjustments during surgery [5][9][10] - The surgical robots are designed to enhance the efficiency and precision of operations, with capabilities such as sub-millimeter accuracy and dynamic calibration of implant positions [10][12] Upcoming Events - The article mentions several upcoming global medical technology conferences, including the first Global Aesthetic Technology Conference in June 2025 and the third Global Surgical Robot Conference in September 2025 [1][12]